{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T06:11:10Z","timestamp":1777183870686,"version":"3.51.4"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammatory factors and vascular endothelial damage are significantly involved in the development of unstable angina pectoris (UAP). Danhong injection (DHI) is a compound injection composed of <jats:italic>Salvia miltiorrhiza<\/jats:italic> and <jats:italic>Carthamus tinctorius<\/jats:italic> extracts. Several clinical studies have demonstrated DHI\u2019s efficacy for treating UAP, with potential pharmacological effects on inflammatory factors and vascular endothelial function. However, to date, the current evidence has not been systematically summarized and analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study provides a comprehensive overview of the most recent clinical findings and systematically analyzes the impact of DHI on inflammatory factors and vascular endothelial function among individuals diagnosed with UAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched for randomized controlled trials (RCTs) conducted until January 2023 from two clinical trial registries and eight literature databases. The Cochrane Risk of Bias Tool 2.0 was utilized to assess the potential bias in the included trials, while the GRADE system was employed to evaluate the outcome quality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 46 trials involving 4,601 patients with UAP. The meta-analysis results suggested that DHI significantly reduced the levels of high-sensitivity C-reactive protein (hs-CRP) (standard mean difference [SMD] = 1.34, 95% confidence interval [CI] [-1.77, \u22120.90], P &amp;lt; 0.00001), tumor necrosis factor-alpha (TNF-\u03b1) (SMD = \u22120.84, 95% CI [-1.54, \u22120.15], P = 0.02), interleukin-6 (IL-6) (SMD = \u22121.05, 95% CI [-1.86, \u22120.25], P = 0.01), endothelin\/endothelin-1 (ET\/ET-1) (SMD = \u22122.01, 95% CI [-2.57, \u22121.46], P &amp;lt; 0.00001), and homocysteine (Hcy) (SMD = \u22120.55, 95% CI [-0.71, \u22120.39], P &amp;lt; 0.00001) but increased the nitric oxide (NO) level (SMD = 1.51, 95% CI [1.04, 1.97], P &amp;lt; 0.00001) in patients with UAP. Twenty-one RCTs described adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>DHI effectively and safely reduced hs-CRP, TNF-\u03b1, IL-6, ET\/ET-1, and Hcy levels and increased the NO level in patients with UAP. However, considering the overall low quality of the original studies, future large-scale, high-quality RCTs are imperative to provide robust evidence for clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p>identifier CRD42023391497.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1389746","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:10:34Z","timestamp":1749795034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of Danhong injection on inflammatory factors and vascular endothelial function in patients with unstable angina pectoris: a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.3389","volume":"16","author":[{"given":"Zunqi","family":"Kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109187","DOI":"10.1016\/j.biopha.2019.109187","article-title":"Pharmacodynamic effects of Dan-hong injection in rats with blood stasis syndrome","volume":"118","author":"Bi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0021-9150(03)00147-3","article-title":"Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function","volume":"169","author":"Bilsborough","year":"2003","journal-title":"Atherosclerosis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1161\/01.cir.0000037106.76139.53","article-title":"ACC\/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/0394632015608247","article-title":"Endothelial immunomediated reactivity in acute cardiac ischaemia: role of endothelin 1, interleukin 8 and NT-proBNP in patients affected by unstable angina pectoris","volume":"29","author":"Caroselli","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3969\/j.issn.1001-9057.2009.08.024","article-title":"Effects of Danhong injection on hemorheology and antioxidation in patients with unstable angina pectoris","volume":"26","author":"Chang","year":"2009","journal-title":"J. Clin. Intern. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jep.2014.04.023","article-title":"Lipid-lowering effects of Danhong injection on hyperlipidemia rats","volume":"154","author":"Chen","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.16367\/j.issn.1003-5028.2015.07.0640","article-title":"Danhong injection for treating 94 cases with unstable angina of blood-stasis pattern","volume":"35","author":"Chen","year":"2015","journal-title":"Henan Tradit. Chin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"114794","DOI":"10.1016\/j.jep.2021.114794","article-title":"Efficacy of add-on Danhong injection in patients with unstable angina pectoris: a double-blind, randomized, placebo-controlled, multicenter clinical trial","volume":"284","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3969\/j.issn.1671-945X.2015.07.026","article-title":"Efficacy and pharmacological action of Danhong injection in the treatment of unstable angina pectoris","volume":"13","author":"Chen S.","year":"2015","journal-title":"J. China Prescr. Drug"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phymed.2018.04.044","article-title":"Efficacy and safety of oral Panax notoginseng saponins for unstable angina patients: a meta-analysis and systematic review","volume":"47","author":"Duan","year":"2018","journal-title":"Phytomedicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.19621\/j.cnki.11-3555\/r.2019.2234","article-title":"Clinical observation of Danhong injection combined with conventional western medicine in the treatment of unstable angina pectoris of coronary heart disease","volume":"27","author":"Duan","year":"2019","journal-title":"China's Naturop."},{"key":"B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jep.2017.10.017","article-title":"Effects of Danhong Injection on platelet aggregation in hyperlipidemia rats","volume":"212","author":"Fan","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"B14","first-page":"14","article-title":"Effect of Danhong injection combined with western medicine on serum inflammatory factors in patients with unstable angina pectoris of coronary heart disease","author":"Feng","year":"2008","journal-title":"Chin. J. Inf. Traditional Chin. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phrs.2018.11.006","article-title":"Danhong injection in cardiovascular and cerebrovascular diseases: pharmacological actions, molecular mechanisms, and therapeutic potential","volume":"139","author":"Feng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3389\/fimmu.2018.02031","article-title":"Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based","volume":"9","author":"Fioranelli","year":"2018","journal-title":"Front. Immunol."},{"key":"B17","first-page":"256","article-title":"Effects of Danhong injection on serum sICAM-1 and hs-CRP in patients with unstable angina pectoris","volume":"34","author":"Fu","year":"2015","journal-title":"J. Electrocardiol. Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000491768","article-title":"Comparison of the effects of ticagrelor and clopidogrel on inflammatory factors, vascular endothelium functions and short-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention: a pilot study","volume":"48","author":"Gao","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.13192\/j.ljtcm.2009.02.78.gaow.008","article-title":"Clinical efficacy of Betong Danhong injection in the treatment of unstable angina pectoris","volume":"36","author":"Gao","year":"2009","journal-title":"Liaoning J. Traditional Chin. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.13210\/j.cnki.jhmu.2012.06.014","article-title":"Effect of Danhong injection on treatment of unstable angina pectoris","volume":"18","author":"Gong","year":"2012","journal-title":"J. Hainan Med. Univ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3969\/j.issn.1674-0742.2007.21.012","article-title":"Effects of Danhong injection on lipid metabolism and endothelial function in patients with unstable angina pectoris","volume":"26","author":"Gong","year":"2007","journal-title":"China Foreign Med. Treat."},{"key":"B22","first-page":"279","article-title":"Influence of folic acid on plasma homocysteine levels and arterial endothelial function in patients with unstable angina","volume":"129","author":"Guo","year":"2009","journal-title":"Indian J. Med. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e21593","DOI":"10.1097\/md.0000000000021593","article-title":"A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome","volume":"99","author":"Guo","year":"2020","journal-title":"Med. Baltim."},{"key":"B24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12906-020-2853-5","article-title":"Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking","volume":"20","author":"Guo","year":"2020","journal-title":"BMC Complement. Med. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2019.11.001","article-title":"Linking regulation of nitric oxide to endothelin-1: the Yin and Yang of vascular tone in the atherosclerotic plaque","volume":"292","author":"Gupta","year":"2020","journal-title":"Atherosclerosis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.15912\/j.cnki.gocm.2012.35.258","article-title":"The effect of Dan red injection on the high sensitivity c-reactive protein of the unstable knot","volume":"10","author":"Han","year":"2012","journal-title":"Guide China Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"B28","first-page":"541","article-title":"Effect of Danhong injection on the expression of serum hs-CRP and Fg in patients with unstable angina pectoris","volume":"44","author":"Hu","year":"2009","journal-title":"Zhejiang J. Traditional Chin. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3870\/yydb.2011.03.018","article-title":"Effects of danhong injection on vascular endothelial function and inflammatory factors in patients with unstable angina pectoris","volume":"30","author":"Hu","year":"2011","journal-title":"Her. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/s0140-6736(16)31961-4","article-title":"Effect of danhong injection on the mobilisation of endothelial progenitor cells to vascular repair after percutaneous coronary intervention: a randomised controlled trial","volume":"388","author":"Hu","year":"2016","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"152850","DOI":"10.1016\/j.phymed.2019.152850","article-title":"Danhong injection mobilizes endothelial progenitor cells to repair vascular endothelium injury via upregulating the expression of Akt, eNOS and MMP-9","volume":"61","author":"Hu","year":"2019","journal-title":"Phytomedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.16766\/j.cnki.issn.1674-4152.2011.08.043","article-title":"Effect of danhong injection on inflammatory factor in patients with unstable angina pectoris","volume":"9","author":"Jia","year":"2011","journal-title":"Chin. J. General Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/tp.0000000000000025","article-title":"Graft reconditioning with nitric oxide gas in rat liver transplantation from cardiac death donors","volume":"97","author":"Kageyama","year":"2014","journal-title":"Transplantation"},{"key":"B34","first-page":"198","article-title":"Clinical observation of the treatment of unstable angina pectoris with danhong injection","volume":"7","author":"Kang","year":"2015","journal-title":"China Contin. Med. Educ."},{"key":"B35","first-page":"295","article-title":"Recommendations for the diagnosis and treatment of unstable angina pectoris","volume":"35","author":"Ke","year":"2007","journal-title":"Chin. J. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/jcm11020373","article-title":"PECAM1, COL4A2, PHACTR1, and LMOD1 gene polymorphisms in patients with unstable angina","volume":"11","author":"Kosi\u0144ski","year":"2022","journal-title":"J. Clin. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3969\/j.issn.1000-7377.2009.08.053","article-title":"Effect of Danhong injection on high-sensitivity C-reactive protein in patients with unstable angina pectoris and its curative effect","volume":"38","author":"Li","year":"2009","journal-title":"Shanxi Med. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.19347\/j.cnki.2096-1413.201821051","article-title":"Clinical effect of Danhong injection in patients with unstable angina pectoris","volume":"3","author":"Li","year":"2018","journal-title":"Clin. Res. Pract."},{"key":"B39","doi-asserted-by":"publisher","first-page":"972738","DOI":"10.3389\/fphar.2022.972738","article-title":"Efficacy and safety of eight types Salvia miltiorrhiza injections in the treatment of unstable angina pectoris: a network meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3969\/j.issn.1000-7377.2018.07.038","article-title":"The effect of Aspirin with Danhong injection on unstable angina pectoris and vascular endothelial function in elderly patients with coronary heart disease","volume":"47","author":"Li","year":"2018","journal-title":"Shaanxi Med. J."},{"key":"B41","first-page":"187","article-title":"Curative effect of danhong injection for unstable angina patients and the level of inflammatory factors in elderly","volume":"34","author":"Li","year":"2016","journal-title":"J. Sichuan Traditional Chin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"610846","DOI":"10.1155\/2015\/610846","article-title":"Postmarketing safety surveillance and reevaluation of danhong injection: clinical study of 30888 cases","volume":"2015","author":"Li","year":"2015","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1029387","DOI":"10.3389\/fcvm.2022.1029387","article-title":"Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3760\/cma.j.issn.1673-4777.2008.06.006","article-title":"Effect of Danhong injection on serum high-sensitivity C-reactive protein in patients with unstable angina pectoris","volume":"3","author":"Liao","year":"2008","journal-title":"China Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.15912\/j.cnki.gocm.2013.01.293","article-title":"Effect of Danhong injection in the treatment of unstable angina pectoris","volume":"11","author":"Liu","year":"2013","journal-title":"Guide China Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.16367\/j.issn.1003-5028.2015.01.0027","article-title":"Effect of Danhong injection on serum hs-CRP and GDF-15 in patients with unstable angina pectoris","volume":"35","author":"Liu","year":"2015","journal-title":"Henan Tradit. Chin. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"857167","DOI":"10.3389\/fphar.2022.857167","article-title":"Danhong injection price trend and its utilization by coronary heart disease patients: evidence from hospital records in China","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B48","first-page":"209","article-title":"Systematic review of Danhong Injection as an adjuvant to conventional Western Medicine in the treatment of unstable angina pectoris","volume":"25","author":"Liu","year":"2016","journal-title":"Lishizhen Med. Materia Medica Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3969\/j.issn.1006-4931.2012.20.067","article-title":"Danhong injection was used to treat 48 cases of unstable angina pectoris of coronary atherosclerotic heart disease","volume":"21","author":"Liu","year":"2012","journal-title":"China Pharm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3969\/j.issn.1008-049X.2018.01.026","article-title":"Efficacy of rosuvastatin combined with danhong injection in the treatment of unstable angina pectoris and influence on serum levels of TNF-\u03b1, hs-CRP and IL-6","volume":"21","author":"Lu","year":"2018","journal-title":"China Pharm."},{"key":"B51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3969\/j.issn.1672-7193.2011.03.047","article-title":"Effect of Danhong injection on vascular endothelial function and cardiac function in patients with unstable angina pectoris","volume":"13","author":"Luo","year":"2011","journal-title":"J. Mil. Surg. Southwest China"},{"key":"B52","first-page":"2664","article-title":"Effect of Danhong injection combined with atorvastatin in the treatment of unstable angina pectoris of coronary heart disease","volume":"37","author":"Lv","year":"2016","journal-title":"J. Oiqihar Med. Univ."},{"key":"B53","doi-asserted-by":"publisher","first-page":"15427","DOI":"10.1038\/s41598-017-14692-3","article-title":"Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection","volume":"7","author":"Lyu","year":"2017","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.13412\/j.cnki.zyyl.2015.01.074","article-title":"Clinical effects of coronary heart disease unstable angina by danhong injection and research on the influence on Hcy, hs-CRP, NT-proBNP","volume":"31","author":"Ma","year":"2015","journal-title":"Pharmacol. Clin. Chin. Materia Medica"},{"key":"B55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fphar.2020.00213","article-title":"Dazhu hongjingtian preparation as adjuvant therapy for unstable angina pectoris: a meta-analysis of randomized controlled trials","volume":"11","author":"Man","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1093\/eurheartj\/ehl308","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology","volume":"27","author":"Messerli","year":"2006","journal-title":"Eur. Heart J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","article-title":"Rating the certainty in evidence in the absence of a single estimate of effect","volume":"22","author":"Murad","year":"2017","journal-title":"Evid. Based Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"114953","DOI":"10.1016\/j.jpba.2022.114953","article-title":"A pharmacokinetic-pharmacodynamic study to elucidate the cardiovascular protective constituents in Danhong Injection","volume":"219","author":"Nijat","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B59","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.phrs.2020.104654","article-title":"Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications","volume":"153","author":"Orgah","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7619\/jcmp.201321033","article-title":"To analyze the clinical efficacy and mechanism of Danhong injection combined with atorvastatin in the treatment of unstable angina pectoris","volume":"17","author":"Pan","year":"2013","journal-title":"J. Clin. Med. Pract."},{"key":"B62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.phymed.2009.08.010","article-title":"Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression","volume":"17","author":"Ren","year":"2010","journal-title":"Phytomedicine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3969\/j.issn.1672-951X.2009.11.010","article-title":"Effect of Danhong injection on inflammatory factors in patients with unstable angina pectoris","volume":"15","author":"Shi","year":"2009","journal-title":"Guid. J. Traditional Chin. Med. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3969\/j.issn.1673-6613.2012.10.019","article-title":"Efficacy observation of 156 cases of senile unstable angina pectoris treated with danhong injection","volume":"7","author":"Shi","year":"2012","journal-title":"World J. Integr. Traditional West. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3969\/j.issn.1672-5085.2011.06.028","article-title":"Effect of danhong injection in treating unstable angina pectoris and on serum high sensitivity C-reactive protein","volume":"8","author":"Sun","year":"2011","journal-title":"Chin. foreign health Abstr."},{"key":"B67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3969\/j.issn.1672-8351.2017.04.102","article-title":"Effects of Danhong injection on hemorheology and vascular endothelial function in elderly patients with unstable angina pectoris","volume":"14","author":"Wang","year":"2017","journal-title":"J. North Pharm."},{"key":"B68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3969\/j.issn.1007-614x.2018.35.054","article-title":"Effect observation of Danhong injection in the treatment of unstable angina pectoris of coronary heart disease","volume":"34","author":"Wang","year":"2018","journal-title":"Chin. Community Dr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11886-017-0919-x","article-title":"Psychological stress, inflammation, and coronary heart disease","volume":"19","author":"Wirtz","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/circresaha.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11655-016-2272-0","article-title":"Danshen injection as adjuvant treatment for unstable angina pectoris: a systematic review and meta-analysis","volume":"23","author":"Wu","year":"2017","journal-title":"Chin. J. Integr. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1142\/s0192415x15500135","article-title":"Danhong injection in the treatment of acute coronary syndrome: a systematic review and meta-analysis","volume":"43","author":"Wu","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1074400","DOI":"10.3389\/fphar.2023.1074400","article-title":"The efficacy and safety of Xueshuantong (lyophilized) for injection in the treatment of unstable angina pectoris: a systematic review and meta-analysis","volume":"14","author":"Xi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3969\/j.issn.1004-5775.2011.09.007","article-title":"Affection of hemorrheology and hyper-sensitive c-rp of danhong injection on unstable angina","volume":"35","author":"Xie","year":"2011","journal-title":"Heilongjiang Med. J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s11655-021-2872-1","article-title":"Effects of danhong injection on peri-procedural myocardial injury and microcirculatory resistance in patients with unstable angina undergoing elective percutaneous coronary intervention: a pilot randomized study","volume":"27","author":"Xing","year":"2021","journal-title":"Chin. J. Integr. Med."},{"key":"B76","first-page":"765","article-title":"Meta-analysis of Danhong Injection in the treatment of unstable angina pectoris","volume":"22","author":"Xu","year":"2011","journal-title":"Front. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3969\/j.issn.1672-1349.2012.10.010","article-title":"Effect of Danhong injection combined with simvastatin on high-sensitivity C-reactive protein in patients with unstable angina pectoris","volume":"10","author":"Xu","year":"2012","journal-title":"Chin. J. Integr. Med. Cardio\/Cerebrovascular Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3969\/j.issn.1007-9149.2009.03.027","article-title":"Effect of Danhong injection on inflammatory factors in patients with unstable angina pectoris","volume":"26","author":"Yang","year":"2009","journal-title":"J. Pingxiang Coll."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3969\/j.issn.1672-1349.2016.17.029","article-title":"Effect of Danhong injection on plasma homocysteine in patients with unstable angina pectoris","volume":"14","author":"Yang","year":"2016","journal-title":"Chin. J. Integr. Med. Cardio\/Cerebrovascular Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"117615","DOI":"10.1016\/j.jep.2023.117615","article-title":"Danhong formula alleviates endothelial dysfunction and reduces blood pressure in hypertension by regulating MicroRNA 24 - phosphatidylinositol 3-Kinase-Serine\/Threonine Kinase- Endothelial Nitric Oxide Synthase axis","volume":"323","author":"Yang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jpba.2018.02.012","article-title":"Investigation of the reverse effect of Danhong injection on doxorubicin-induced cardiotoxicity in H9c2 cells: insight by LC-MS based non-targeted metabolomic analysis","volume":"152","author":"Yi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.3969\/j.issn.1005-9202.2018.13.008","article-title":"Effect of Danhong injection on homocysteine and high-sensitivity C-reactive protein expression in elderly patients with unstable angina pectoris","volume":"38","author":"Yin","year":"2018","journal-title":"Chin. J. Gerontology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"903","DOI":"10.12102\/j.issn.1672-1349.2018.07.021","article-title":"Clinical efficacy of Danhong injection combined with simvastatin in the treatment of unstable angina pectoris","volume":"16","author":"Yu","year":"2018","journal-title":"Chin. J. Integr. Med. Cardio\/Cerebrovascular Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3969\/j.issn.1674-0947.2021.04.003","article-title":"The clinical effects of danhong injection combined with rosuvastatin in the treatment of uap","volume":"43","author":"Yu","year":"2021","journal-title":"J. Shandong Med. Coll."},{"key":"B85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12944-018-0760-2","article-title":"The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials","volume":"17","author":"Yu","year":"2018","journal-title":"Lipids Health Dis."},{"key":"B86","first-page":"77","article-title":"Clinical effect of Danhong injection in the treatment of patients with unstable angina pectoris of coronary heart disease","volume":"6","author":"Zhang","year":"2021","journal-title":"Doctor"},{"key":"B87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3969\/j.issn.1671-4008.2009.07.017","article-title":"Therapeutic effect of Danhong injection on unstable angina pectoris","volume":"26","author":"Zhang","year":"2009","journal-title":"Pract. J. Med. & Pharm."},{"key":"B88","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3969\/j.issn.1009-4393.2010.31.109","article-title":"Effect of Danhong injection on high-sensitivity C-reactive protein and hemorheology in patients with unstable angina pectoris","volume":"16","author":"Zhang","year":"2010","journal-title":"Contemp. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3969\/j.issn.0253-9926.2017.013.009","article-title":"Clinical efficacy of Danhong injection combined with rosuvastatin in the treatment of unstable angina pectoris and its influence on serum inflammatory factors and hemorheology","volume":"46","author":"Zhang","year":"2017","journal-title":"Shanxi Med. J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"182","DOI":"10.13194\/j.issn.1673-842x.2015.09.063","article-title":"Effects of danhong injection on unstable factors and vascular endothelial function of inflammation in patients with angina pectoris","volume":"17","author":"Zhao","year":"2015","journal-title":"J. Liaoning Univ. Traditional Chin. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3969\/j.issn.1005-1457.2011.086","article-title":"Clinical application and evaluation of danhong injection for patients with unstable angina","volume":"19","author":"Zhao","year":"2011","journal-title":"Sichuan J. Anat."},{"key":"B92","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fphar.2018.00550","article-title":"The therapeutic efficacy of danhong injection combined with percutaneous coronary intervention in acute coronary syndrome: a systematic review and meta-analysis","volume":"9","author":"Zou","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1389746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:11:08Z","timestamp":1749795068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1389746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":92,"alternative-id":["10.3389\/fphar.2025.1389746"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1389746","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"article-number":"1389746"}}